Clinical Trials Logo

Clinical Trial Summary

The purpose of this prospective pilot study is to gather preliminary evidence evaluating spinal cord stimulation (SCS) as a potential therapy for the treatment of rigidity and painful spasms in patients with stiff person syndrome (SPS), a rare autoimmune neurological condition. The hypothesis is that SCS-mediated clinical improvement occurs through multi-modal mechanisms of action targeting several components of neuronal inhibitory signaling pathways in the spinal cord.


Clinical Trial Description

The hypothesis is that SCS-mediated clinical improvement occurs through multi-modal mechanisms of action targeting several components of neuronal inhibitory signaling pathways in the spinal cord. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06242678
Study type Interventional
Source Wake Forest University Health Sciences
Contact Janus S Patel, MD
Phone 336-716-4498
Email jspatel@wakehealth.edu
Status Not yet recruiting
Phase N/A
Start date August 2024
Completion date April 2025

See also
  Status Clinical Trial Phase
Terminated NCT02282514 - Stem Cell Transplantation for Stiff Person Syndrome (SPS) Phase 1/Phase 2
Not yet recruiting NCT04106596 - HLA Analysis in Autoimmune Encephalitis and Related Disorders
Not yet recruiting NCT03829826 - Efficacy and Mechanism of Action of SCIg in Patients With Stiff Person Syndrome (SPS)
Completed NCT00030940 - Cause, Development, and Progression of Stiff-Person Syndrome N/A
Withdrawn NCT03749096 - Randomized Placebo Controlled Trial of IVIg in Glycine Receptor Antibody Positive Stiff-person Syndrome Phase 3